Skip to Content

JACOBUS 25 102 (Dapsone 25 mg)

Pill with imprint JACOBUS 25 102 is White, Round and has been identified as Dapsone 25 mg. It is supplied by Jacobus Pharmaceutical Company.

Dapsone is used in the treatment of dermatitis herpetiformis; leprosy; leprosy, lepromatous; leprosy, tuberculoid; pneumocystis pneumonia and belongs to the drug class leprostatics. Risk cannot be ruled out during pregnancy. Dapsone 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for JACOBUS 25 102

Dapsone 25 mg JACOBUS 25 102
Dapsone 25 mg JACOBUS 25 102
Dapsone 25 mg JACOBUS 25 102 Front
Dapsone 25 mg JACOBUS 25 102 Back
Dapsone 25 mg JACOBUS 25 102

Dapsone

Imprint
JACOBUS 25 102
Strength
25 mg
Color
White
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Leprostatics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Jacobus Pharmaceutical Company
Inactive Ingredients
silicon dioxide, magnesium stearate, microcrystalline cellulose, corn starch

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
49938-0102 Jacobus Pharmaceutical Company Inc.
13925-0504 Seton Pharmaceuticals LLC
55289-0188 PDRX Pharmaceuticals Inc. (repackager)
54868-2817 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.